The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 16, 1992

Filed:

Nov. 30, 1989
Applicant:
Inventors:

Paul J Conlon, III, Seattle, WA (US);

David j Cosman, Seattle, WA (US);

Kenneth H Grabstein, Seattle, WA (US);

Thomas P Hopp, Seattle, WA (US);

Shirley R Kronheim, Seattle, WA (US);

Alf D Larsen, Seattle, WA (US);

Carl J March, Seattle, WA (US);

Virginia L Price, Seattle, WA (US);

Douglas P Cerretti, Seattle, WA (US);

Assignee:

Immunex Corporation, Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P / ; C12P / ; C12N / ; C12N / ;
U.S. Cl.
CPC ...
435 6952 ; 435 691 ; 435 91 ; 4351723 ; 4353201 ; 435255 ; 435256 ; 536 27 ; 530350 ; 935 13 ; 935 28 ; 935 37 ; 935 56 ; 935 61 ; 935 69 ;
Abstract

Double-stranded cDNA is prepared from polyadenylated RNA extracted from activated human peripheral blood adherent mononuclear cells. The cDNA is inserted within a plasmid vector and then the recombinant plasmid employed to transform an appropriate host. Transformed hosts are identified and grouped into pools. Plasmid DNA prepared from these pools is hybridized with a labeled, synthetic oligonucleotide probe corresponding to a portion of the amino acid sequence of the interleukin 1 protein. Pools of host cells that provide a positive signal to the probe are identified, plated out and then employed in direct bacterial colony hybridization with the same probe, thereby to isolate the particular positive colony. Plasmid DNA is prepared from this colony and characterized by restriction enzyme mapping and sequencing by chain-termination method. The coding region for the IL-1 gene is inserted into a shuttle vector for amplification of the vector followed by expression of functional IL-1.


Find Patent Forward Citations

Loading…